News
News
“Canada’s drug access debate has two ends: patients are caught in the middle,” Op-Ed by Arthritis Consumer Experts (ACE)
ACE submitted an Op-Ed to the Globe and Mail, Canada’s national newspaper of record in response to an article focused ...
Gaming the system: An overview of originator companies’ evergreening strategies used to hinder access to generic and biosimilar products
This report from the International Generic and Biosimilar Medicines Association looks at the various strategies ...
Patients and patents campaign partners launch website
Prescription drug prices continue to rise around the world, putting essential medications out of reach for too many people living ...
Interview: Patients and patents – Understanding how pharmaceutical patents affect medication cost
This Arthritis Consumer Experts Arthritis At Home explores why some medications are so expensive and the role pharmaceutical patents play ...
Beyond regulatory delays: How patent misuse impacts access to affordable medications
This Globe and Mail op-ed calls attention to how brand-name manufacturers are using the patent system to block affordable biosimilars ...
How pharmaceutical patents make drugs expensive
In this video, science communicator Patrick Kelly uses engaging visuals and storytelling to explain the pharmaceutical patent system ...
The unspoken cost of pharma IP protections from trade agreements
This infographic illustrates how trade agreements can increase drug prices by embedding extended intellectual property protections ...
Why are drug prices so high?
This TED Talk by Priti Krishtel expresses how lack of transparency and misuse of patent protections are key contributions to ...
